Elevated D-dimers in attacks of hereditary angioedema are not associated with increased thrombotic risk

Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial

(2014) Marc A. Riedl et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Endothelial cell activation during edematous attacks of hereditary angioedema types I and II

(2014) Erika Kajdácsi et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Contact System Activation on Endothelial Cells

(2014) Steven de Maat et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study

(2013) Marc A. Riedl et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Population pharmacokinetics of recombinant human C1 inhibitor in patients with hereditary angioedema

(2013) Colm Farrell et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Ongoing Contact Activation in Patients with Hereditary Angioedema

(2013) Joke Konings et al.   PLoS One

Recombinant human C1 inhibitor for the prophylaxis of hereditary angioedema attacks: a pilot study

(2012) A. Reshef et al.   ALLERGY

Characterization of recombinant human C1 inhibitor secreted in milk of transgenic rabbits

(2012) Harrie A. van Veen et al.   JOURNAL OF BIOTECHNOLOGY

Thrombotic Events Associated with C1 Esterase Inhibitor Products in Patients with Hereditary Angioedema: Investigation from the United States Food and Drug Administration Adverse Event Reporting System Database

(2012) Pranav K. Gandhi et al.   PHARMACOTHERAPY

D-Dimer Assays in Diagnosis and Management of Thrombotic and Bleeding Disorders

(2012) Shannon Bates   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Recombinant C1-Inhibitor

(2011) Anurag Relan et al.   BIODRUGS

Alterations of coagulation and fibrinolysis in patients with angioedema due to C1-inhibitor deficiency

(2011) M. van Geffen et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Identification of kallikrein and FXIa as impurities in therapeutic immunoglobulins: implications for the safety and control of intravenous blood products

(2011) M. Etscheid et al.   VOX SANGUINIS

Enzymatic pathways in the pathogenesis of hereditary angioedema: The role of C1 inhibitor therapy

(2010) Allen P. Kaplan   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema

(2010) Bruce Zuraw et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Kinetics of D-dimer after general surgery

(2009) Daniel Dindo et al.   BLOOD COAGULATION & FIBRINOLYSIS

Corn trypsin inhibitor decreases tissue-type plasminogen activator-mediated fibrinolysis of human plasma

(2009) Vance G Nielsen   BLOOD COAGULATION & FIBRINOLYSIS

Association of vital exhaustion and depressive symptoms with changes in fibrin D-dimer to acute psychosocial stress

(2009) Roland von Känel et al.   JOURNAL OF PSYCHOSOMATIC RESEARCH

Factor XII: What does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis

(2009) Evi Stavrou et al.   THROMBOSIS RESEARCH

Plasma biomarkers of acute attacks in patients with angioedema due to C1-inhibitor deficiency

(2008) M. Cugno et al.   ALLERGY

D-dimer antigen: current concepts and future prospects

(2008) S. S. Adam et al.   BLOOD